source
- FDA shift sparks renewed pharma and VC focus on osteoporosis drug developmentThe FDA recently altered its regulatory framework for osteoporosis medicines, prompting a wave of renewed interest across the pharmaceutical sector. Earlier, drugs from Eli Lilly, Merck, Novartis…
- Insurers UnitedHealth, CVS, and Kaiser oppose Medicare's contractor ban on remote patient monitoringMajor insurers including UnitedHealth Group, CVS Health and Kaiser Permanente have formally objected to a new Medicare proposal that would change billing for remote patient monitoring (RPM). The p…